Results 171 to 180 of about 67,645 (203)

Correction to: Association of accelerated phenotypic aging, lifestyle and genetic risk with progression of cardiometabolic multimorbidity: a multi‑state model analysis. [PDF]

Geroscience
Shi Y, Wu H, Pan L, Liu Y, Huang C, Yu Y, Qin G, He L.   +7 more
europepmc   +1 more source

Combined associations of the frailty index and CHG index with cardiometabolic multimorbidity: a longitudinal study from the CHARLS cohort. [PDF]

Front Nutr
Huang L, Yan X, Wang Y, Ti Y, Bu P, Li J.   +5 more
europepmc   +1 more source

Lifestyle, Cardiometabolic Disease, and Multimorbidity in a Prospective Chinese Study [PDF]

European Heart Journal, 2021
Abstract Aims  The potential difference in the impacts of lifestyle factors (LFs) on progression from healthy to first cardiometabolic disease (FCMD), subsequently to cardiometabolic multimorbidity (CMM), and further to death is unclear.
Ling Yang, Liming Li, Zhengming Chen
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Role of Pulmonary Function in Predicting New-Onset Cardiometabolic Diseases and Cardiometabolic Multimorbidity

Chest, 2022
Although pulmonary function has been studied in relationship to individual cardiometabolic diseases, uncertainty persists about the difference in risk magnitudes of pulmonary function for these diseases and its association with cardiometabolic multimorbidity (CM).Does pulmonary function have different risk magnitudes for cardiometabolic diseases and CM?
Yanan Qiao, Chaofu Ke, Yanqiang Lu
exaly   +3 more sources

Correlation of Cardiometabolic Index and Sarcopenia With Cardiometabolic Multimorbidity in Middle-Aged and Older Adult: A Prospective Study

Frontiers in Endocrinology
BackgroundResearch has demonstrated that sarcopenia and visceral obesity are significant risk factors for chronic disease in middle-aged and older adults. However, the relationship between sarcopenia, the cardiac metabolic index (CMI), a novel measure of visceral obesity, and cardiometabolic multimorbidity (CMM) remains unclear.
Huaijun Tu, ling He, Yansong Tu
exaly   +4 more sources

Hyperuricemia, circulating metabolites, and the risk of cardiometabolic multimorbidity

Clinica Chimica Acta
The role of hyperuricemia in cardiometabolic multimorbidity (CMM) needs to be further confirmed. We aimed to investigate the impact of hyperuricemia on cardiometabolic multimorbidity, and to explore the metabolic mechanisms.We conducted a prospective cohort study using data from 422,058 participants in the UK Biobank. Cardiometabolic multimorbidity was
Ziyi, Zhou, Yin, Wu, Yuan, Fei, Jiaheng, Chu, Shuo, Jiang, Weisheng, Xu, Xiaoqi, Zheng, Hui, Wang   +7 more
openaire   +2 more sources

Association of depression severity and transition patterns of cardiometabolic multimorbidity

Journal of Affective Disorders
We aimed to assess the association of depression severity with the incidence and progression of cardiometabolic multimorbidity (CMM) in middle-aged and older Chinese adults.We analyzed data from 12,059 participants in the China Health and Retirement Longitudinal Study (CHARLS). Depression severity was categorized as none, mild-moderate, or severe using
Jiya, Zhang, Bingxin, Jiang, Yajing, Zhou, Yahang, Liu, Chen, Huang, Ruilang, Lin, Lulu, Pan, Junbo, Ge, Juan, Peng, Yongfu, Yu   +9 more
openaire   +2 more sources